A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
An eight-week, randomized, double blind, two parallel groups, study to assess clinical
response of duloxetine 60 milligrams (mg) and 120 mg per day in patients hospitalized for
severe depression.